Medical Weight Loss for Naperville, Illinois Residents
Naperville, Illinois residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month, serving Naperville through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Naperville Residents Choose New Hope Weight Loss
A lot of clinics talk about supervision in the abstract. We can name the person doing it. Dr. Anjmun Sharma, MD oversees every Naperville case personally, which means your dose, your check-ins, and your safety calls are decisions a single physician owns from start to finish. Compounded GLP-1 medication deserves that kind of continuity, and we would rather give you one accountable doctor than a queue of interchangeable ones.
Naperville residents do not need a local clinic to start. Our physician-led program is delivered by secure video from Costa Mesa, California, with flat nationwide pricing and compounded medication mailed in cold-pack packaging to your Naperville address.
You do not need a clinic on your street in Naperville to work with a real physician, because everything Dr. Sharma offers from Costa Mesa reaches patients across Illinois by secure telehealth. We care for patients throughout Downtown Naperville, the Riverwalk, and the greater west-suburban Chicago area. Wherever you live in Illinois, your medication ships straight to your door in discreet packaging, so the same care reaches you whether you are in Naperville proper or one of the surrounding Downtown Naperville, the Riverwalk, and the greater west-suburban Chicago area.
Patients on the outskirts of Illinois get the same flat pricing, the same physician, and the same fast start as those near the center of Naperville. Patients anywhere in Illinois, including the Downtown Naperville, the Riverwalk, and the greater west-suburban Chicago area neighborhoods, get the same pricing because care is delivered by telehealth from our Costa Mesa clinic. From the big cities to the small towns of Illinois, New Hope Weight Loss provides physician-supervised GLP-1 care by secure telehealth from our Costa Mesa, California clinic.
GLP-1 Weight Loss Programs Available
Start with the 90-Day Metabolic Reset
Semaglutide anchors our most-requested program, and it shares an active ingredient with Wegovy and Ozempic. You can begin from $166 a month, or cover all 90 days for $499. In trials of the branded medication, average body-weight loss landed around 15 to 17 percent, though results vary and compounded semaglutide is neither FDA-approved nor brand-identical. Patients across Naperville meet with Dr. Sharma entirely by telehealth.
Step up to tirzepatide when it fits
Priced from $233 a month, tirzepatide pairs GLP-1 with GIP for a dual effect. Branded-drug trials recorded up to 22.5 percent loss at qualifying doses, a ceiling figure, not an average. Same active ingredient as Mounjaro and Zepbound.
Everything opens with a $119 physician review. Medication billed separately. We take HSA, FSA, Klarna, and Affirm.
How Telehealth Works for Naperville
Telehealth means your weight-loss care travels to you instead of the other way around. Patients across Naperville and the rest of start with a detailed online quiz covering medical history and goals. Dr. Anjmun Sharma personally reviews each intake and connects by secure video, usually inside 48 hours, to decide together whether a compounded GLP-1 is right. When she writes a prescription, the medication is filled by a state-licensed 503(a) pharmacy and mailed to your Naperville door in temperature-controlled cold-pack packaging. Ongoing follow-ups also happen by video, keeping your plan on track without a single in-person appointment.
Frequently Asked Questions, Naperville
Does New Hope Weight Loss actually serve Naperville, or only Costa Mesa?
We serve both. Our single physical location sits in Costa Mesa, California, and we extend care to Naperville, Illinois through telehealth. Residents across neighborhoods like Downtown Naperville, the Riverwalk, and the greater west-suburban Chicago area qualify the same way. Dr. Anjmun Sharma evaluates whether a compounded GLP-1 plan fits you during your initial video appointment.
Can the whole process be done remotely from Naperville?
Yes, it is fully remote. There is no in-person requirement for Naperville patients at any stage. You meet Dr. Sharma over video, complete intake online, and receive ongoing support by message. Approved prescriptions arrive at your door in insulated cold-pack shipping that protects the medication during delivery.
How much will a Naperville patient pay?
Plan on $119 for the physician visit. Semaglutide runs from $166 monthly, with a $499 option for 90 days, and tirzepatide from $233 monthly. The medication cost is separate from the visit. HSA, FSA, Klarna, and Affirm are all welcome, and Naperville residents pay no added distance fee.
What areas of Naperville do you serve?
We serve patients from across Naperville by telehealth, including Downtown Naperville, the Riverwalk, and the greater west-suburban Chicago area.
Are there hidden fees for Naperville patients?
No. Naperville patients pay the same flat, stated pricing: a $119 physician visit, then compounded semaglutide from $166/month or tirzepatide from $233/month with medication billed separately. There is no membership lock-in and no distance surcharge.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Naperville, Illinois by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.